Warts Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Warts are skin growth that is caused by a virus called human papillomavirus (HPV). HPV infects the top layer of skin, usually entering the body in an area of broken skin. The virus causes the top layer of skin to grow rapidly, forming a wart. Symptoms include pain and rough skin. Predisposing factors include age and people with weakened immune systems, such as those with HIV/AIDS or people who had organ transplants.
The Warts Drugs in Development market research report provides an in-depth analysis of the warts pipeline landscape. The report provides comprehensive information on the therapeutics under development for Warts, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for warts and features dormant and discontinued projects.
Warts Pipeline Drugs Market Targets
The targets of the warts pipeline drugs market are Bacterial Cell Membrane, Cyclin Dependent Kinase 9, Human Papillomavirus Major Capsid Protein L1, Integrin Alpha 4, Integrin Alpha V, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Interleukin 10, RNA, and Toll Like Receptor 7.
Warts Pipeline Drugs Market, By Targets
For more target insights, download a free report sample
Mechanisms of Action of Warts Pipeline Drugs Market
The mechanisms of action of the warts pipeline drugs market are Bacterial Cell Membrane Disruptor, Cyclin Dependent Kinase 9 Inhibitor, Integrin Alpha 4 Antagonist, Integrin Alpha V Antagonist, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Interleukin 10 Inhibitor, RNA Synthesis Inhibitor, Toll Like Receptor 7 Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 1A Agonist.
Warts Pipeline Drugs Market, By Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Routes of Administration in Warts Pipeline Drugs Market
The routes of administration in the warts pipeline drugs market are topical, intramuscular, cutaneous, parenteral, transdermal, vaginal, intravenous, ophthalmic, subcutaneous, and intradermal.
Warts Pipeline Drugs Market, By Routes of Administration
For more routes of administration insights, download a free report sample
Molecule Types in Warts Pipeline Drugs Market
The molecule types in the warts pipeline drugs market are small molecule, subunit vaccine, cell therapy, recombinant vector vaccine, vaccine, DNA vaccine, peptide, protein, recombinant enzyme, recombinant protein, and synthetic peptide.
Warts Pipeline Drugs Market, By Molecule Types
For more molecule type insights, download a free report sample
Key Warts Pipeline Drugs Market Companies
Some of the key companies in the warts pipeline drugs market are KinoPharma Inc, Verrica Pharmaceuticals Inc, Novan Inc, Shanghai Bovax Biotechnology Co Ltd, Xiamen Innovax Biotech Co Ltd, Aclaris Therapeutics Inc, Beijing Kangle Guardian Biotechnology Co Ltd, Chengdu Institute of Biological Products Co Ltd, Cutanea Life Sciences Inc, and Cytovation AS.
Warts Pipeline Drugs Market, By Key Companies
To know more about key companies, download a free report sample
Market report overview
| Targets | Bacterial Cell Membrane, Cyclin Dependent Kinase 9, Human Papillomavirus Major Capsid Protein L1, Integrin Alpha 4, Integrin Alpha V, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Interleukin 10, RNA, and Toll Like Receptor 7 |
| Mechanisms of Action | Bacterial Cell Membrane Disruptor, Cyclin Dependent Kinase 9 Inhibitor, Integrin Alpha 4 Antagonist, Integrin Alpha V Antagonist, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Interleukin 10 Inhibitor, RNA Synthesis Inhibitor, Toll Like Receptor 7 Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 1A Agonist |
| Routes of Administration | Topical, Intramuscular, Cutaneous, Parenteral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, and Intradermal |
| Molecule Types | Small Molecule, Subunit Vaccine, Cell Therapy, Recombinant Vector Vaccine, Vaccine, DNA Vaccine, Peptide, Protein, Recombinant Enzyme, Recombinant Protein, and Synthetic Peptide |
| Key Companies | KinoPharma Inc, Verrica Pharmaceuticals Inc, Novan Inc, Shanghai Bovax Biotechnology Co Ltd, Xiamen Innovax Biotech Co Ltd, Aclaris Therapeutics Inc, Beijing Kangle Guardian Biotechnology Co Ltd, Chengdu Institute of Biological Products Co Ltd, Cutanea Life Sciences Inc, and Cytovation AS |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of warts (Infectious Disease).
- Reviews of pipeline therapeutics for warts (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in warts (Infectious Disease) therapeutics and enlists all their major and minor projects.
- Evaluation of Warts (Infectious Disease) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Warts (Infectious Disease).
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for warts (Infectious Disease). Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding warts (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Beijing Kangle Guardian Biotechnology Co Ltd
Chengdu Institute of Biological Products Co Ltd
Cutanea Life Sciences Inc
Cytovation AS
Douglas Pharmaceuticals Ltd
Etna Biotech Srl
Feramda Ltd
G&E Herbal Biotechnology Co., Ltd.
Genetic Immunity Inc
Guangzhou Cape Biological Technology Co Ltd
Hefei Ruichengsheng Biotechnology Co Ltd
KinoPharma Inc
Laboratories Ojer Pharma SL
Maruho Co Ltd
Merck & Co Inc
Nielsen Biosciences Inc
Novan Inc
Orgenesis Inc
Peritech Pharma
Phio Pharmaceuticals Corp
Shanghai Bovax Biotechnology Co Ltd
Shanghai Zerun Biotechnology Co Ltd
SinoCelltech Group Ltd
Veloce BioPharma LLC
Verrica Pharmaceuticals Inc
Xiamen Innovax Biotech Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the warts pipeline drugs market?
The targets of the warts pipeline drugs market are Bacterial Cell Membrane, Cyclin Dependent Kinase 9, Human Papillomavirus Major Capsid Protein L1, Integrin Alpha 4, Integrin Alpha V, Interferon Alpha/Beta Receptor 1, Interferon Alpha/Beta Receptor 2, Interleukin 10, RNA, and Toll Like Receptor 7.
-
What are the mechanisms of action of the warts pipeline drugs market?
The mechanisms of action of the warts pipeline drugs market are Bacterial Cell Membrane Disruptor, Cyclin Dependent Kinase 9 Inhibitor, Integrin Alpha 4 Antagonist, Integrin Alpha V Antagonist, Interferon Alpha/Beta Receptor 1 Agonist, Interferon Alpha/Beta Receptor 2 Agonist, Interleukin 10 Inhibitor, RNA Synthesis Inhibitor, Toll Like Receptor 7 Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 1A Agonist.
-
What are the routes of administration in the warts pipeline drugs market?
The routes of administration in the warts pipeline drugs market are topical, intramuscular, cutaneous, parenteral, transdermal, vaginal, intravenous, ophthalmic, subcutaneous, and intradermal.
-
What are the molecule types in the warts pipeline drugs market?
The molecule types in the warts pipeline drugs market are small molecule, subunit vaccine, cell therapy, recombinant vector vaccine, vaccine, DNA vaccine, peptide, protein, recombinant enzyme, recombinant protein, and synthetic peptide.
-
Which are the key companies in the warts pipeline drugs market?
Some of the key companies in the warts pipeline drugs market are KinoPharma Inc, Verrica Pharmaceuticals Inc, Novan Inc, Shanghai Bovax Biotechnology Co Ltd, Xiamen Innovax Biotech Co Ltd, Aclaris Therapeutics Inc, Beijing Kangle Guardian Biotechnology Co Ltd, Chengdu Institute of Biological Products Co Ltd, Cutanea Life Sciences Inc, and Cytovation AS.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Infectious Disease reports